GREY WOLF THERAPEUTICS
Grey Wolf Therapeutics is a UK-based drug discovery biotechnology company focused on immuno-oncology. Rather than targeting the immune system, Grey Wolf’s approach is to directly alter the tumour cells, illuminating them for attack and destruction by the immune system. THey are targeting the endoplasmic reticulum aminopeptidases (ERAP) 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells, thus dramatically increasing tumour visibility and extending the reach of immunotherapy in oncology. Grey Wolf is working with leading academic and commercial drug discovery partners to deliver a clinical candidate against a strongly validated target.
GREY WOLF THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.greywolftherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+44 1865 292 038
Email Addresses:
[email protected]
Total Funding:
17.5 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Current Employees Featured
Founder
Investors List
Andera Partners
Andera Partners investment in Series A - Grey Wolf Therapeutics
Canaan Partners
Canaan Partners investment in Series A - Grey Wolf Therapeutics
Canaan Partners
Canaan Partners investment in Series A - Grey Wolf Therapeutics
Andera Partners
Andera Partners investment in Series A - Grey Wolf Therapeutics
Official Site Inspections
http://www.greywolftherapeutics.com Semrush global rank: 4.4 M Semrush visits lastest month: 2.54 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Grey Wolf Therapeutics"
Greywolf – About us
Greywolf is a clinical-stage biotech company advancing novel antigen modulation technology which controls T cells to guide the immune system.See details»
Greywolf Therapeutics
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.See details»
Greywolf Therapeutics - Crunchbase Company Profile …
Grey Wolf Therapeutics raised €46 million in a Series B round to develop disease-modifying therapies for autoimmune disorders. Additionally, the …See details»
Grey Wolf Therapeutics Overview | SignalHire Company Profile
Organization Website. greywolftherapeutics.com . Social Links. Phone Number +44 1865 292 038. Grey Wolf Therapeutics industries. Biotech Headquarters Location. 99 Park Dr,, Milton, …See details»
Greywolf – Tom McCarthy
Tom is a Co-founder and Non-executive Chairperson of Greywolf Therapeutics and brings over 25 years of experience in drug discovery, development and commercialization to the team. …See details»
Greywolf – Careers
We are an agile team of scientists, clinicians and professionals on a mission to deliver a new therapeutic class of antigen modulators to treat people living with autoimmune disorders, …See details»
Greywolf Therapeutics - LinkedIn
Central Park, 43, 152-158 St Georges Terrace Perth, Western Australia 6000, AUSee details»
Grey Wolf Therapeutics - PitchBook
Jan 9, 2020 Grey Wolf Therapeutics General Information Description. Developer of drug discovery platform intended to offer oncology therapies that focus on immune oncology. The …See details»
Grey Wolf Therapeutics - 2025 Company Profile - Tracxn
3 days ago Grey Wolf Therapeutics - Developer of small molecule based therapeutics for cancer treatment. Raised a total funding of $113M over 3 rounds from 10 investors. Founded by Peter …See details»
Grey Wolf Therapeutics - Overview, News & Similar companies
Grey Wolf Therapeutics contact info: Phone number: +44 1235644970 Website: www.greywolftherapeutics.com What does Grey Wolf Therapeutics do? Grey Wolf …See details»
Grey Wolf Therapeutics - Org Chart, Teams, Culture & Jobs - The …
View Grey Wolf Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
GreyWolf Therapeutics - Craft
GreyWolf Therapeutics has 5 employees across 2 locations and $19.87 m in total funding,. See insights on GreyWolf Therapeutics including office locations, competitors, revenue, financials, …See details»
Grey Wolf Therapeutics - Oxford Science Enterprises
Latest News All Company News 23•05•24 Portfolio News Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences Team, to …See details»
Grey Wolf Therapeutics Ltd. (Grey Wolf Therapeutics Ltd.) - 药物管 …
Founding CEO, Stuart Hughes, Ph.D., to Transition to Chief Scientific Officer and Focus Efforts on Advancing Company's First-of-its-Kind GPR65 Inhibition Approach to Immuno-Oncology …See details»
Grey Wolf Therapeutics - Seedtable
Get information on funding, investors, industries, and more for Grey Wolf Therapeutics. See Grey Wolf Therapeutics company profile and funding data.See details»
Grey Wolf Therapeutics Announces Formation of Clinical Advisory …
Feb 15, 2022 For more information, please visit: www.greywolftherapeutics.com. Contacts: Grey Wolf Therapeutics Peter Joyce Chief Executive Officer +44 (0) 01865 292 038 [email protected]See details»
Greywolf Therapeutics - LinkedIn
Greywolf Therapeutics | 4,198 followers on LinkedIn. We are advancing novel antigen modulation technology that controls T cells to guide the immune system. | Many cancers and other …See details»
Greywolf Therapeutics closes oversubscribed $50m Series B …
About Greywolf Therapeutics Greywolf Therapeutics is a clinical-stage biotech company advancing novel antigen modulation technology that controls T cells to guide the immune system.See details»
Greywolf Therapeutics, Ltd. | Insights
Jul 8, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series …
May 23, 2024 /PRNewswire/ -- Grey Wolf Therapeutics ("Grey Wolf" or "the company"), a clinical-stage biotechnology company leveraging first-of-its-kind antigen modulation...See details»